Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2016, Article ID 1360348, 6 pages
http://dx.doi.org/10.1155/2016/1360348
Review Article

The Structure and Clinical Roles of MicroRNA in Colorectal Cancer

Division of Gastroenterology and Hepatology, Key Laboratory of Gastroenterology and Hepatology, Ministry of Health and State Key Laboratory for Oncogenes and Related Genes, Renji Hospital, Shanghai Jiao Tong University, Shanghai Institution of Digestive Disease, 145 Middle Shandong Road, Shanghai 200001, China

Received 18 July 2016; Accepted 11 October 2016

Academic Editor: Nicola Silvestris

Copyright © 2016 Linwensi Zhu and Jingyuan Fang. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Siegel, C. Desantis, and A. Jemal, “Colorectal cancer statistics, 2014,” CA Cancer Journal for Clinicians, vol. 64, no. 2, pp. 104–117, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. R. C. Lee, R. L. Feinbaum, V. Ambros, and C. The, “The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14,” Cell, vol. 75, no. 5, pp. 843–854, 1993. View at Publisher · View at Google Scholar
  3. S. Griffiths-Jones, R. J. Grocock, S. van Dongen, A. Bateman, and A. J. Enright, “miRBase: microRNA sequences, targets and gene nomenclature,” Nucleic Acids Research, vol. 34, pp. D140–D144, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. J. G. Doench and P. A. Sharp, “Specificity of microRNA target selection in translational repression,” Genes and Development, vol. 18, no. 5, pp. 504–511, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Eulalio, E. Huntzinger, T. Nishihara, J. Rehwinkel, M. Fauser, and E. Izaurralde, “Deadenylation is a widespread effect of miRNA regulation,” RNA, vol. 15, no. 1, pp. 21–32, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. L. Wu, J. Fan, and J. G. Belasco, “MicroRNAs direct rapid deadenylation of mRNA,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 11, pp. 4034–4039, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. O. A. Kent and J. T. Mendell, “A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes,” Oncogene, vol. 25, no. 46, pp. 6188–6196, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Z. Michael, S. M. O'Connor, N. G. Van Holst Pellekaan, G. P. Young, and R. J. James, “Reduced accumulation of specific MicroRNAs in colorectal neoplasia,” Molecular Cancer Research, vol. 1, no. 12, pp. 882–891, 2003. View at Google Scholar · View at Scopus
  9. O. Slaby, M. Svoboda, P. Fabian et al., “Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer,” Oncology, vol. 72, no. 5-6, pp. 397–402, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. X. M. Xu, J. C. Qian, Z. L. Deng et al., “Expression of miR-21, miR-31, miR-96 and miR-135b is correlated with the clinical parameters of colorectal cancer,” Oncology Letters, vol. 4, no. 2, pp. 339–345, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Liu, G. Li, C. Fan, X. Zhou, B. Wu, and J. Li, “Increased expression of MicroRNA-21 and its association with chemotherapeutic response in human colorectal cancer,” Journal of International Medical Research, vol. 39, no. 6, pp. 2288–2295, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. N. Oue, K. Anami, A. J. Schetter et al., “High miR-21 expression from FFPE tissues is associated with poor survival and response to adjuvant chemotherapy in colon cancer,” International Journal of Cancer, vol. 134, no. 8, pp. 1926–1934, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. W. K. Kang, J. K. Lee, S. T. Oh, S. H. Lee, and C. K. Jung, “Stromal expression of miR-21 in T3-4a colorectal cancer is an independent predictor of early tumor relapse,” BMC Gastroenterology, vol. 15, no. 1, article 2, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. C.-J. Wang, Z.-G. Zhou, L. Wang et al., “Clinicopathological significance of microRNA-31, -143 and -145 expression in colorectal cancer,” Disease Markers, vol. 26, no. 1, pp. 27–34, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. P. Faltejskova, M. Svoboda, K. Srutova et al., “Identification and functional screening of microRNAs highly deregulated in colorectal cancer,” Journal of Cellular and Molecular Medicine, vol. 16, no. 11, pp. 2655–2666, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Gaedcke, M. Grade, J. Camps et al., “The rectal cancer microRNAome—microRNA expression in rectal cancer and matched normal mucosa,” Clinical Cancer Research, vol. 18, no. 18, pp. 4919–4930, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. P. Akçakaya, S. Ekelund, I. Kolosenko et al., “miR-185 and miR-133b deregulation is associated with overall survival and metastasis in colorectal cancer,” International Journal of Oncology, vol. 39, no. 2, pp. 311–318, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. L. He, J. M. Thomson, M. T. Hemann et al., “A microRNA polycistron as a potential human oncogene,” Nature, vol. 435, no. 7043, pp. 828–833, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. B. Diosdado, M. A. Van De Wiel, J. S. Terhaar Sive Droste et al., “MiR-17-92 cluster is associated with 13q gain and c-myc expression during colorectal adenoma to adenocarcinoma progression,” British Journal of Cancer, vol. 101, no. 4, pp. 707–714, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. N. Nishida, M. Nagahara, T. Sato et al., “Microarray analysis of colorectal cancer stromal tissue reveals upregulation of two oncogenic miRNA clusters,” Clinical Cancer Research, vol. 18, no. 11, pp. 3054–3070, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. G. Yu, J.-Q. Tang, M.-L. Tian et al., “Prognostic values of the miR-17-92 cluster and its paralogs in colon cancer,” Journal of Surgical Oncology, vol. 106, no. 3, pp. 232–237, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Zhou, G. Zhang, Z. Liu, S. Xia, and H. Tian, “Overexpression of miR-92a correlates with tumor metastasis and poor prognosis in patients with colorectal cancer,” International Journal of Colorectal Disease, vol. 28, no. 1, pp. 19–24, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. A. J. Schetter, S. Y. Leung, J. J. Sohn et al., “MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma,” JAMA—Journal of the American Medical Association, vol. 299, no. 4, pp. 425–436, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. H. Ogata-Kawata, M. Izumiya, D. Kurioka et al., “Circulating exosomal microRNAs as biomarkers of colon cancer,” PLoS ONE, vol. 9, no. 4, Article ID e92921, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. Z. Fang, J. Tang, Y. Bai et al., “Plasma levels of microRNA-24, microRNA-320a, and microRNA-423-5p are potential biomarkers for colorectal carcinoma,” Journal of Experimental and Clinical Cancer Research, vol. 34, article 86, 2015. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Hu, G. Cai, Y. Xu, and S. Cai, “The Plasma microRNA miR-1914 and miR-1915 suppresses chemoresistant in colorectal cancer patients by down-regulating NFIX,” Current Molecular Medicine, vol. 16, no. 1, pp. 70–82, 2016. View at Publisher · View at Google Scholar
  27. J. K. Lee, E. G. Liles, S. Bent, T. R. Levin, and D. A. Corley, “Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysis,” Annals of Internal Medicine, vol. 160, no. 3, pp. 171–181, 2014. View at Google Scholar · View at Scopus
  28. F. E. Ahmed, C. D. Jeffries, P. W. Vos et al., “Diagnostic microRNA markers for screening sporadic human colon cancer and active ulcerative colitis in stool and tissue,” Cancer Genomics and Proteomics, vol. 6, no. 5, pp. 281–295, 2009. View at Google Scholar · View at Scopus
  29. A. Link, F. Balaguer, Y. Shen et al., “Fecal microRNAs as novel biomarkers for colon cancer screening,” Cancer Epidemiology Biomarkers & Prevention, vol. 19, no. 7, pp. 1766–1774, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. T. O. Yau, C. W. Wu, Y. Dong et al., “microRNA-221 and microRNA-18a identification in stool as potential biomarkers for the non-invasive diagnosis of colorectal carcinoma,” British Journal of Cancer, vol. 111, no. 9, pp. 1765–1771, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. C. W. Wu, S. C. Ng, Y. Dong et al., “Identification of microrna-135b in stool as a potential noninvasive biomarker for colorectal cancer and adenoma,” Clinical Cancer Research, vol. 20, no. 11, pp. 2994–3002, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. Y. Zhu, A. Xu, J. Li et al., “Fecal miR-29a and miR-224 as the noninvasive biomarkers for colorectal cancer,” Cancer Biomarkers, vol. 16, no. 2, pp. 259–264, 2016. View at Publisher · View at Google Scholar
  33. S. A. Ciafrè and S. Galardi, “microRNAs and RNA-binding proteins: a complex network of interactions and reciprocal regulations in cancer,” RNA Biology, vol. 10, no. 6, pp. 927–935, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. J. D. Marth, R. Peet, E. G. Krebs, and R. M. Perlmutter, “A lymphocyte-specific protein-tyrosine kinase gene is rearranged and overexpressed in the murine T cell lymphoma LSTRA,” Cell, vol. 43, no. 2, part 1, pp. 393–404, 1985. View at Publisher · View at Google Scholar · View at Scopus
  35. L. H. Gregersen, A. B. Jacobsen, L. B. Frankel, J. Wen, A. Krogh, and A. H. Lund, “MicroRNA-145 targets YES and STAT1 in colon cancer cells,” PLoS ONE, vol. 5, no. 1, Article ID e8836, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Sachdeva and Y.-Y. Mo, “MicroRNA-145 suppresses cell invasion and metastasis by directly targeting mucin 1,” Cancer Research, vol. 70, no. 1, pp. 378–387, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. X. Chen, X. Guo, H. Zhang et al., “Role of miR-143 targeting KRAS in colorectal tumorigenesis,” Oncogene, vol. 28, no. 10, pp. 1385–1392, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. E. K. O. Ng, W. P. Tsang, S. S. M. Ng et al., “MicroRNA-143 targets DNA methyltransferases 3A in colorectal cancer,” British Journal of Cancer, vol. 101, no. 4, pp. 699–706, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. Y. Zhang, Z. Wang, M. Chen et al., “MicroRNA-143 targets MACC1 to inhibit cell invasion and migration in colorectal cancer,” Molecular Cancer, vol. 11, article 23, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. B. Zhou, J. Song, T. Han et al., “MiR-382 inhibits cell growth and invasion by targeting NR2F2 in colorectal cancer,” Molecular Carcinogenesis, vol. 55, no. 12, pp. 2260–2267, 2016. View at Publisher · View at Google Scholar
  41. B. Li, Z. Xie, and B. Li, “miR-152 functions as a tumor suppressor in colorectal cancer by targeting PIK3R3,” Tumor Biology, vol. 37, no. 8, pp. 10075–10084, 2016. View at Publisher · View at Google Scholar · View at Scopus
  42. M.-H. Yang, J. Yu, D.-M. Jiang, W.-L. Li, S. Wang, and Y.-Q. Ding, “MicroRNA-182 targets special AT-rich sequence-binding protein 2 to promote colorectal cancer proliferation and metastasis,” Journal of Translational Medicine, vol. 12, no. 1, article 109, 2014. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Dews, A. Homayouni, D. Yu et al., “Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster,” Nature Genetics, vol. 38, no. 9, pp. 1060–1065, 2006. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Tsuchida, S. Ohno, W. Wu et al., “miR-92 is a key oncogenic component of the miR-17-92 cluster in colon cancer,” Cancer Science, vol. 102, no. 12, pp. 2264–2271, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. G. Zhang, H. Zhou, H. Xiao, Z. Liu, H. Tian, and T. Zhou, “MicroRNA-92a functions as an oncogene in colorectal cancer by targeting PTEN,” Digestive Diseases and Sciences, vol. 59, no. 1, pp. 98–107, 2014. View at Publisher · View at Google Scholar · View at Scopus
  46. J. S. Mandel, J. H. Bond, T. R. Church et al., “Reducing mortality from colorectal cancer by screening for fecal occult blood,” The New England Journal of Medicine, vol. 328, no. 19, pp. 1365–1371, 1993. View at Publisher · View at Google Scholar · View at Scopus
  47. M. Di Lena, E. Travaglio, and D. F. Altomare, “New strategies for colorectal cancer screening,” World Journal of Gastroenterology, vol. 19, no. 12, pp. 1855–1860, 2013. View at Publisher · View at Google Scholar · View at Scopus
  48. X. Chen, Y. Ba, L. Ma et al., “Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases,” Cell Research, vol. 18, no. 10, pp. 997–1006, 2008. View at Publisher · View at Google Scholar · View at Scopus
  49. J. Lu, G. Getz, E. A. Miska et al., “MicroRNA expression profiles classify human cancers,” Nature, vol. 435, no. 7043, pp. 834–838, 2005. View at Publisher · View at Google Scholar · View at Scopus
  50. H.-G. Li, L.-H. Zhao, X.-B. Bao, P.-C. Sun, and B.-P. Zhai, “Meta-analysis of the differentially expressed colorectal cancer-related microRNA expression profiles,” European Review for Medical and Pharmacological Sciences, vol. 18, no. 14, pp. 2048–2057, 2014. View at Google Scholar · View at Scopus
  51. E. K. O. Ng, W. W. S. Chong, H. Jin et al., “Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening,” Gut, vol. 58, no. 10, pp. 1375–1381, 2009. View at Publisher · View at Google Scholar · View at Scopus
  52. Z. Huang, D. Huang, S. Ni, Z. Peng, W. Sheng, and X. Du, “Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer,” International Journal of Cancer, vol. 127, no. 1, pp. 118–126, 2010. View at Publisher · View at Google Scholar · View at Scopus
  53. Y. Yu, F. H. Sarkar, and A. P. N. Majumdar, “Down-regulation of miR-21 induces differentiation of chemoresistant colon cancer cells and enhances susceptibility to therapeutic regimens,” Translational Oncology, vol. 6, no. 2, pp. 180–186, 2013. View at Publisher · View at Google Scholar · View at Scopus
  54. S. Roy, Y. Yu, S. B. Padhye, F. H. Sarkar, and A. P. N. Majumdar, “Difluorinated-Curcumin (CDF) restores PTEN expression in colon cancer cells by down-regulating miR-21,” PLoS ONE, vol. 8, no. 7, Article ID e68543, 2013. View at Publisher · View at Google Scholar · View at Scopus
  55. L. Fang, H. Li, L. Wang et al., “MicroRNA-17-5p promotes chemotherapeutic drug resistance and tumour metastasis of colorectal cancer by repressing PTEN expression,” Oncotarget, vol. 5, no. 10, pp. 2974–2987, 2014. View at Publisher · View at Google Scholar · View at Scopus
  56. Y. Yannan and Z. Haihang, “Progress of microRNA-499 in the colorectal cancer,” Chinese Journal of Gastroenterology and Hepatology, vol. 24, no. 5, pp. 498–500, 2015. View at Google Scholar
  57. Y. Wang, Q. Tang, M. Li, S. Jiang, and X. Wang, “MicroRNA-375 inhibits colorectal cancer growth by targeting PIK3CA,” Biochemical and Biophysical Research Communications, vol. 444, no. 2, pp. 199–204, 2014. View at Publisher · View at Google Scholar · View at Scopus
  58. D. Shi, B. Zhai, Y. Zheng, R. Ren, M. Han, and X. Wang, “Transcatheter arterial infusion chemotherapy increases expression level of miR-142-5p in stage III colorectal cancer,” Indian Journal of Cancer, vol. 52, no. 6, pp. e47–e55, 2015. View at Publisher · View at Google Scholar · View at Scopus